Leadership Team - VERO Biotech

Brent Furse

CEO and President

Brent Furse has served as a Director and our Chief Executive Officer and President since June 2016. Prior to coming to VERO Biotech, Mr. Furse was a key member of The Medicines Company leadership team where he joined in 2000 pre-IPO and served as a section 16 Officer.

Brent has held various leadership positions including Executive Vice President, Chief Operating Officer, Chief Commercial Officer, Vice President and General Manager Interventional Medicine, Vice President Surgery and Perioperative Care, and Vice President of Sales and Marketing. He was responsible for the launch and success of their flagship product Angiomax, as well as countless successful partnerships and operational excellence. In addition to his success at The Medicines Company, Brent has held leadership positions with Centers for Disease Control and Prevention, Bristol-Myers Squibb, and Schering Plough Corporation, and serves on the board of Anthera Pharmaceuticals, The Special Olympics and Salus Tele-health.

White Handwritten Love on Black Background Square Pillow-4

NATE PINKARD

Director of Human Strategies

Nate Pinkard has been a Human Resources leader for 23 years with Fortune 50, Middle Market and Small Business operations. His focus is on driving employee relations, performance management, training & development and risk mitigation.

Prior to coming to VERO Biotech, Nate has held positions as Director of Human Resources, Assurance America; EEO Compliance & HR Service Operations Manager, Insperity and Senior Manager, HR, The Home Depot Corporation. He holds Business degrees in Human Resources and Business Management from The University of TN and is a Military Veteran.

Michelle Nickoli

Vice President of Customer Engagement

Michelle joined VERO Biotech sales team for the launch of the GENOSYL Delivery System. She is a healthcare and patient-centric business professional with over twenty-two years experience in building positions driven by quality and results.

Ms. Nickoli brings a track record of demonstrated consistent achievement of organizational goals, strong sales, performance, and quality objectives. Michelle is a Registered Respiratory Therapist and holds a Bachelors Degree in Sales and Marketing. She started her career as an RRT at Bellin Hospital and Aurora HealthCare before moving into the medical device industry at Possis Medical and pharmaceutical industry with The Medicines Company and Melinta Therapeutics. Michelle has built and lead several successful customer facing teams for 10 acute care product launches in various therapeutic areas such as infectious disease, surgical, emergency medicine, and cardiovascular. Her passion for presenting patient focused messages is invaluable, as well as in leading and bringing teams to action that result in completion of common goals.

White Handwritten Love on Black Background Square Pillow-7

Roberto Cohen

Chief Financial Officer

Roberto Cohen joined VERO Biotech in May of 2021. Roberto previously served as Head of M&A for a healthcare portfolio company of Patria Investments, Blackstone’s Private Equity arm in Latin America. During the 3-year project, he was based in Brazil to execute the company’s inorganic growth strategy, leading to the creation of one of the largest hospital distributors in the region.

Prior to relocating to Brazil, Roberto was Director of M&A at NY-based healthcare distributor Henry Schein. During his twelve years there, he contributed to dozens of international deals, primarily in Europe and Latin America. His involvement expanded beyond the transactional process and included active involvement in integrating the acquired entities.

Roberto holds a Masters of Business Administration from the Wharton Business School and a Bachelor degree in Economics from PUC-Rio de Janeiro.

Shasha Zou

General Counsel & Corporate Secretary

Shasha Zou joined VERO Biotech as General Counsel and Corporate Secretary in November 2020 and oversees VERO’s legal activities and policies. Shasha has extensive experience handling complex disputes and counseling on risk on behalf of pharmaceutical and healthcare companies all across the nation.

Prior to joining VERO, Shasha was an attorney in private practice at King & Spalding and Orrick, Herrington & Sutcliffe. She holds a Juris Doctor degree from Duke University School of Law.

KATIE FISHER

Chief Technical Officer

Katie Fisher joined Vero Biotech in 2018 with over 15 years’ experience in the medical device, tissue, and pharmaceutical industries. Katie has extensive experience leading teams across multiple functions, including Engineering, Technical Operations, Quality, and Regulatory.

Brent Furse

NATE PINKARD

Michelle Nickoli

Roberto Cohen

Shasha Zou

KATIE FISHER

Contact Info

Quick Links

Medical Inquiries